Mankind Pharma Reports 22% Revenue Growth, Net Profit Up 203% In Q4 FY26
Published on: May 19, 2026, 7:35 p.m. | Source: Free Press Journal
Mankind Pharma reported 22 percent growth in Q4 FY26 revenue to Rs 2,581.8 crore, while net profit surged 203 percent to Rs 713.6 crore. Profit growth was supported by lower tax expenses, improved operating performance, and contributions from the women’s health business acquired from Bharat Serums and Vaccines.
